CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (2,174,654)	$ (831,812)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	166,033	131,343
Amortization of insurance premium	30,242	25,188
Non-cash operating lease cost	18,871	14,254
Stock-based compensation	193,432	352,245
Inventory and firm purchase commitments write-downs	734,495	364,553
Other non-cash items	(46,990)	(5,020)
Changes in operating assets and liabilities:
Accounts receivable	(3,778)	489
Inventory	(575,933)	(906,054)
Prepaid expenses	(43,062)	(12,101)
Other current assets	13,680	(33,262)
Other noncurrent assets	(113,790)	(39,082)
Accounts payable	(114,810)	52,216
Accrued compensation	(1,781)	16,644
Operating lease liabilities	(17,500)	(10,761)
Other current liabilities	(44,005)	281,545
Other long-term liabilities	25,993	20,191
Net cash used in operating activities	(2,015,204)	(1,577,743)
Cash flows from investing activities:
Purchases of property, plant and equipment	(638,002)	(784,964)
Purchases of investments	(3,585,254)	(2,726,677)
Proceeds from maturities of investments	2,480,570	125,353
Proceeds from sale of investments	148,388	0
Proceeds from government grant	0	97,267
Other investing activities	(4,827)	0
Net cash used in investing activities	(1,599,125)	(3,289,021)
Cash flows from financing activities:
Payment for short-term insurance financing note	0	(15,330)
Payment for finance lease liabilities	(4,534)	(3,605)
Proceeds from borrowings	42,920	20,228
Repayments for borrowings	0	(6,653)
Proceeds from failed sale-leaseback transaction	0	31,700
Proceeds from exercise of stock options	7,321	14,738
Proceeds from employee stock purchase plan	15,089	12,882
Tax withholding payments for net settlement of employee awards	(14,705)	(212,895)
Net cash provided by (used in) financing activities	3,042,956	(165,566)
Net decrease in cash, cash equivalents, and restricted cash	(571,373)	(5,032,330)
Beginning cash, cash equivalents, and restricted cash	1,737,320	6,298,020
Ending cash, cash equivalents, and restricted cash	1,165,947	1,265,690
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amounts capitalized	7,933	11,307
Cash paid for taxes	37	480
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property, plant and equipment included in accounts payable and other current liabilities	77,844	65,267
Property, plant and equipment and right-of-use assets obtained through leases	26,572	143,972
Line of Credit
Cash flows from financing activities:
Payment for credit facility issuance costs	0	(6,631)
Underwriting Agreement
Cash flows from financing activities:
Proceeds from issuance of common stock	1,184,224	0
Private Placement
Cash flows from financing activities:
Proceeds from issuance of common stock	1,812,641	0
Change in fair value of common stock warrant liability
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of common stock warrant liability	$ (61,647)	$ (998,319)